Oct 20 |
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts?
|
Oct 19 |
Biogen Inc. (BIIB): Worst Performing NASDAQ Stock in 2024
|
Oct 17 |
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce
|
Oct 16 |
State Street Corp's Strategic Acquisition of Biogen Inc Shares
|
Oct 16 |
Biogen (BIIB): Pioneering CNS Treatments and Future Growth Prospects
|
Oct 10 |
The Latest Analyst Ratings For Biogen
|
Oct 10 |
Biogen reinstated at market perform at Raymond James on Leqembi disappointment
|
Oct 10 |
Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report?
|
Oct 10 |
Biogen scores breakthrough status for anti-rejection transplant medication
|
Oct 9 |
Biogen’s kidney transplant rejection candidate gets FDA breakthrough designation
|